Alemtuzumab in the treatment of IVIG-dependent chronic inflammatory demyelinating polyneuropathy. (2010)

First Author: Marsh EA

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s00415-009-5437-3

PubMed Identifier: 20049473

Publication URI: http://europepmc.org/abstract/MED/20049473

Type: Journal Article/Review

Volume: 257

Parent Publication: Journal of neurology

Issue: 6

ISSN: 0340-5354